Orion Genomics
Stage
Series A | AliveAbout Orion Genomics
Provider of molecular diagnostic products, epigenetics research tools, and genomics and clinical research services. The company brings cutting edge scientific expertise, innovation, proprietary technologies and commercial, and academic partnerships throughout the globe. It aims to change how the world approaches feeding, fueling and healing itself.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Orion Genomics Patents
Orion Genomics has filed 1 patent.
The 3 most popular patent topics include:
- Electrophysiology
- Laboratory equipment
- Laboratory glassware
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
11/25/2019 | 3/8/2022 | Laboratory equipment, Laboratory glassware, Molecular biology, Electrophysiology, Sample return missions | Grant |
Application Date | 11/25/2019 |
|---|---|
Grant Date | 3/8/2022 |
Title | |
Related Topics | Laboratory equipment, Laboratory glassware, Molecular biology, Electrophysiology, Sample return missions |
Status | Grant |
Orion Genomics Frequently Asked Questions (FAQ)
Where is Orion Genomics's headquarters?
Orion Genomics's headquarters is located at 20 South Sarah Street, Saint Louis.
What is Orion Genomics's latest funding round?
Orion Genomics's latest funding round is Series A.
Who are the investors of Orion Genomics?
Investors of Orion Genomics include Finney Capital.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
